Delivery Order SPE2DB20D3111-SPE2DB25FA6LU

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,448.15 firm fixed-price delivery order is for the supply of FEMRING 0.05 MG/DAY vaginal rings. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $2,098.70 under a broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which runs through January 2025, is for the delivery of FEMRING 0.05 MG/DAY vaginal rings. This contract award is not designated as a set-aside and represents an open competition. Amerisourcebergen holds a $999,999,999 IDC with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,537.38 Firm Fixed Price Delivery Order contract is for the supply of FEMRING 0.05 MG/DAY VAG RINGS, a vaginal ring medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,324.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FEMRING 0.10 MG/DAY vaginal rings, with a completion date of February 23, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,069.10, is a delivery order for the supply of FEMRING 0.10 MG/DAY VAG RINGS, a pharmaceutical product. The contract has a period of performance through October 16, 2024 and utilizes a firm fixed-price pricing structure. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
This is a delivery order under contract SPE2DB20D3104 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide FEMRING 0.05 MG/DAY vaginal rings. The $3,865.93 firm-fixed-price order has an ultimate completion date of August 18, 2021. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical through November 2026, which covers a...
This federal contract award is a delivery order (SPE2DB22FT9W9) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FEMRING 0.10 MG/DAY vaginal rings. The $1,647.15 fixed-price contract was awarded on June 30, 2022 by the Defense Logistics Agency (DLA), with an ultimate completion date of July 1, 2022. The contract is not designated under any set-aside program. Amerisourcebergen, a for-profit organization, is a key vendor for federal healthcare programs,...
This is a $1,193.47 fixed-price delivery order awarded to the Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of FEMRING 0.05 MG/DAY vaginal rings to the U.S. government. The award was made by the Medical Supply Chain, a defense agency under the Defense Logistics Agency (DLA) Troop Support. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of FEMRING 0.10 MG/DAY VAG RINGS. The firm-fixed price delivery order, valued at $5,190.49, has a completion date of January 3, 2025. AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, is the prime contractor and does not have any major subcontractors listed. The contract is not designated as a set-aside. AmerisourceBergen also holds a $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of FEMRING 0.05 MG/DAY vaginal rings, with a potential value of $2,884.82 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA6LU
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,921.53, is for the delivery of FEMRING 0.05 MG/DAY vaginal rings. The contract is a Firm Fixed Price Delivery Order with a completion date of January 30, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

This contract award was not designated with a set-aside requirement, indicating open competition. No subcontractors were mentioned in the provided information.

Generated 4/30/25, 9:44 AM